Spartacus Acquisition Corp. II (NASDAQ:TMTS – Get Free Report) was the recipient of a large increase in short interest during the month of October. As of October 30th, there was short interest totaling 6,763 shares, an increase of 650.6% from the October 15th total of 901 shares. Based on an average daily volume of 271,082 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a “sell (e)” rating on shares of Spartacus Acquisition Corp. II in a research note on Wednesday. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.
View Our Latest Analysis on TMTS
Spartacus Acquisition Corp. II Stock Down 0.1%
Shares of TMTS stock traded down $0.01 during trading hours on Thursday, hitting $10.02. 185 shares of the company were exchanged, compared to its average volume of 132,521. The company’s fifty day moving average price is $10.03. Spartacus Acquisition Corp. II has a 52-week low of $9.90 and a 52-week high of $10.45.
Spartacus Acquisition Corp. II Company Profile
Spartacus Acquisition Corp. II is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with one or more operating businesses. Its potential transactions may include a merger, share exchange, asset acquisition, reorganization or similar corporate combination. As a blank-check company, Spartacus Acquisition Corp. II does not operate a traditional commercial business and does not offer products or services of its own. Its activities are focused primarily on evaluating potential target companies and pursuing an appropriate transaction.
Further Reading
- Five stocks we like better than Spartacus Acquisition Corp. II
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
- 3 Pharmaceutical Stocks That Offer Safety and Growth
Receive News & Ratings for Spartacus Acquisition Corp. II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spartacus Acquisition Corp. II and related companies with MarketBeat.com's FREE daily email newsletter.
